首页|早期经络注血疗法治疗慢阻肺急性加重患者的临床效果评价

早期经络注血疗法治疗慢阻肺急性加重患者的临床效果评价

扫码查看
目的 探讨早期经络注血疗法治疗慢性阻塞性肺疾病(慢阻肺)急性加重患者的临床疗效。方法 采用随机对照试验方法,将符合纳入标准的 60 例慢阻肺急性加重患者随机分为经络注血组及对照组,各 30 例。两组患者均予以西医基础治疗,经络注血组在此基础上予以早期经络注血疗法治疗。于入院时及出院时评价患者治疗前后咳嗽严重程度评分、痰液粘稠度、呼吸困难程度评分、慢阻肺健康损害情况评分,并比较两组的变化值。结果 经络注血组入院时和出院时视觉模拟评分法(VAS)评分、改良英国MRC呼吸困难分级量表(mMRC)评分、慢性阻塞性肺病评估测试(CAT)评分变化值分别为(4。48±2。22)、(1。65±0。40)、(16。34±8。10)分,均大于对照组的(1。94±1。50)、(0。92±0。23)、(12。08±5。86)分,差异具有统计学意义(P<0。05);经络注血组入院时和出院时痰液粘稠度下降程度(1。24±0。59)度大于对照组的(1。08±0。20)度,但差异不具有统计学意义(P>0。05)。结论 予以早期经络注血疗法治疗慢阻肺急性加重患者能有效减轻咳嗽严重程度,缓解呼吸困难程度,使慢阻肺急性加重患者临床症状得到更有效的改善,值得推广。
Evaluation of clinical effect of early meridian blood injection therapy in patients with acute exacerbation of chronic obstructive pulmonary disease
Objective To explore the clinical efficacy of early meridian blood injection therapy in patients with acute exacerbation of chronic obstructive pulmonary disease.Methods Using the randomized controlled trial method,60 patients with acute exacerbation of chronic obstructive pulmonary disease included in the access criteria were randomly divided into a meridian blood injection group and a control group,with 30 cases in each group.All patients were treated with basic treatment of Western medicine,and the meridian blood injection group was given early meridian blood injection therapy on this basis.At the time of admission and discharge,the cough severity score,sputum viscosity grading,dyspnea severity score and chronic obstructive pulmonary disease health damage score were evaluated before and after treatment,and the variation between the two groups were compared.Results The variation visual analogue scale(VAS)score,modified British medical research council(mMRC)score,and chronic obstructive pulmonary disease assessment test(CAT)score of the meridian blood injection group at admission and discharge were(4.48±2.22),(1.65±0.40),and(16.34±8.10)points,which were higher than(1.94±1.50),(0.92±0.23),and(12.08±5.86)point of the control group,and the difference was statistically significant(P<0.05).The decline in sputum viscosity of meridian injection group at admission and discharge was(1.24±0.59)degree,which was greater than(1.08±0.20)degree of the control group,but the difference was not statistically significant(P>0.05).Conclusion Early meridian blood injection therapy for patients with acute exacerbation of chronic obstructive pulmonary disease can effectively reduce the severity of cough,effectively alleviate the degree of dyspnea,and make the clinical symptoms of chronic obstructive pulmonary disease patients more effectively controlled,which is worth promoting.

Meridian blood injection therapyChronic obstructive pulmonary diseaseAcute exacerbationEarly intervention

谢波、周惠仪、叶剑聪、刘兴华

展开 >

523000 东莞市中西医结合医院

经络注血疗法 慢性阻塞性肺疾病 急性加重 早期干预

东莞市社会发展科技项目东莞市社会发展科技项目林琳东莞市名中医药专家传承工作室建设项目

20211800904122东科通202181号东卫函[2020]136号

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(2)
  • 16